Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by ConcertAI
ConcertAI Appoints Missy Jerome as Chief People Officer
March 26, 2026
From
ConcertAI
Via
Business Wire
ConcertAI Launches Accelerated Clinical Trials, Leveraging Agentic AI to Radically Shorten Trial Timelines
February 02, 2026
From
ConcertAI
Via
Business Wire
ConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Development
January 12, 2026
From
ConcertAI
Via
Business Wire
ConcertAI Introduces TeraRecon AV™, Advancing AI-Powered Medical Imaging with New Structural Heart and SaaS Capabilities
November 20, 2025
From
ConcertAI
Via
Business Wire
ConcertAI’s TeraRecon DETECT™ Helps Identify Opportunities to Optimize AI Imaging Reimbursement Workflows, Expanding Patient Access to the Most Advanced Care
November 20, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology
October 21, 2025
From
ConcertAI
Via
Business Wire
ConcertAI’s TeraRecon Surpasses 2,000 Global Customers, Accelerating Cloud-First SaaS Transformation to Further Unlock Productivity for Healthcare Providers
September 25, 2025
From
ConcertAI
Via
Business Wire
Casey Graves Joins ConcertAI as General Manager, Clinical Solutions
September 11, 2025
From
ConcertAI
Via
Business Wire
CancerLinQ Receives ASCO Certified™ RQS Recognition Enabling Automated Quality Tracking That Helps Oncology Care Practices Save Critical Time and Resources
August 27, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Appoints Michael Myshrall as Chief Financial Officer
August 18, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Provides Intelligent Automation of ASCO® Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ® SmartLinQ™ Solutions
May 31, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Launches New Generative and Agentic AI-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences
May 30, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth
May 01, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
April 22, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
April 22, 2025
From
ConcertAI
Via
Business Wire
EY US unveils Jeff Elton of ConcertAI as an Entrepreneur Of The Year® 2025 New England Award finalist
April 21, 2025
From
ConcertAI
Via
Business Wire
ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers
March 29, 2025
From
ConcertAI
Via
Business Wire
Exigent Research, Leading National Community Research Network, Partners with AI Leader ConcertAI to Integrate CARAai™ Precision Trial Solutions
February 03, 2025
From
ConcertAI
Via
Business Wire
ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025
March 18, 2025
From
ConcertAI
Via
Business Wire
ConcertAI Presents at 43rd Annual J.P. Morgan Healthcare Conference: 2024 Results and 2025-2028 AI Solutions Roadmap
January 13, 2025
From
ConcertAI
Via
Business Wire
At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors
February 03, 2025
From
ConcertAI
Via
Business Wire
ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research
December 05, 2024
From
ConcertAI
Via
Business Wire
ConcertAI Announces Cloud-Based SaaS Transformation of TeraRecon Portfolio, Expanding its AI-Enhanced Clinical Capabilities in Medical Imaging
December 02, 2024
From
ConcertAI
Via
Business Wire
TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform
October 23, 2024
From
ConcertAI
Via
Business Wire
ConcertAI Appoints James Salitan as General Counsel
October 01, 2024
From
ConcertAI
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
